NL-OMON47646
Completed
Not Applicable
Cardiovascular Disease in Children with chronic inflammation - CDC study (cardiovascular disease in children)
niversitair Medisch Centrum Utrecht0 sites116 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversitair Medisch Centrum Utrecht
- Enrollment
- 116
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •General criteria for all groups:
- •\* 12\-19 years of age ;Obese adolescents:
- •Definition according to the international standards of the International Obesity Task Force, see Cole et al, BMJ, 2000\. ;JIA adolescents:
- •\* Polyarticular course JIA, including polyarticular JIA and extended oligoarticular JIA, rheumafactor negatieve. These patients often suffer from lifelong rheumatic disease, and are therefore at risk for early atherosclerosis.
- •\* More than 1 year after diagnosis. In first year of disease, patients undergo multiple study procedures, causing a burden on patients. In order to reduce the general burden, this study will focus on patients after their first year of disease.
- •\* BMI\-SD \< 2 (no obese children). ;Corrected aortic arch anomalies adolescents:
- •\* Corrected aortic arch anomalies, i.e. hypoplastic aortic arch, coarctatio aortae, interrupted aortic arch. These patients are at risk for hypertension and early atherosclerosis.
- •\* BMI\-SD (standard deviation from BMI corrected for age and sex) \< 2, to prevent including obese children in this group, to prevent obesity being a confounder in later analysis. ;Cystic fibrosis adolescents:
- •\- Established cystic fibrosis, all mutations.
- •\- BMI\-SD \< 2, to prevent inclusion of obese children so that obesity cannot be a confounder in later analysis. ;Corrected ASD adolescents:
Exclusion Criteria
- •A potential subject who meets any of the following criteria will be excluded from participation in this study:
- •\* Intoxication (smoking, drug\-use)
- •\* Acute illness (fever)
- •\* Mental retardation
- •\* Claustrophobia
- •\* A history of allergic reactions to MR contrast fluids
- •\* Implanted electronic devices (i.e. pacemaker, internal cardioverter\-defibrillator, cochlear implants, nerve\- and bone stimulators)
- •\* Subjects with ferromagnetic clips in brain, eyes or lungs
- •\* A known reduced kidney function (GFR\< 60 ml/min/1\.73m2\)
- •\* Pregnancy
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Cardiovascular function in children with heart failure with preserved ejection fractioJPRN-UMIN000010821Saitama Medical Center, Saitama Medical School40
Not yet recruiting
Not Applicable
Cardiovascular risk profile in pediatric CAH patients: a cross-sectional studyCongenital aderenal hyperplasia10001353NL-OMON38496niversitair Medisch Centrum Sint Radboud80
Completed
Not Applicable
Cardiovascular Comorbidity in Children With Chronic Kidney DiseaseChildhood Chronic Kidney DiseaseNCT03227055Chang Gung Memorial Hospital155
Recruiting
Not Applicable
Profile of heart diseases in patients with chronic kidney diseaseCTRI/2019/02/017847Kasturba Medical College Manipal
Recruiting
Not Applicable
Progression and heart related outcomes of kidney diseaseHealth Condition 1: N18- Chronic kidney disease (CKD)CTRI/2019/05/019025Griffith University